Lumicell
MA - NewtonBiotechnology
Focus: Lumicell is a early-stage biotechnology company specializing in fluorescent cancer imaging device technology, operating from Massachusetts with a focus on intraoperative oncology applications.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
2-1 this month
Stable — net -1 jobs in 30d
1 added, 2 removed. Backfill posture.
Should You Work at Lumicell?
AI assessmentHigh-risk, high-reward opportunity suitable only for early-stage biotech enthusiasts willing to build company infrastructure from the ground up with uncertain funding visibility.
Why Work Here
- First-mover advantage in tumor-targeted fluorescent imaging with LUMISIGHT (pegulicianine) approved by FDA and entering growth phase with LOE protection until 2034
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Growth8.3yr
FDA-approved fluorescent imaging agent targeting tumor-associated proteases; 10-year patent protection enables multiple oncology indication expansions.
Help build intelligence for Lumicell
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.